Imunon, Inc. (IMNN) — Financial statements
Income statement, balance sheet, and cash flow for Imunon, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00↓100.0% | 0.50↑0.0% | 0.50 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00↓100.0% | 0.50↑0.0% | 0.50 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↓33.2% | 12↑3.1% | 11↓3.8% | 12↑10.5% | 11 | |
| General & Administrative Expenses | 7↓8.3% | 7↓23.1% | 10↓28.8% | 14↑25.7% | 11 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7↓8.3% | 7↓23.1% | 10↓28.8% | 14↑25.7% | 11 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 15↓23.4% | 19↓9.0% | 21↓17.3% | 25↑18.2% | 22 | |
| Total Costs & Expenses | 15↓23.4% | 19↓9.0% | 21↓17.3% | 25↑18.2% | 22 | |
| Operating Results | ||||||
| Operating Income | -15↑23.4% | -19↑9.0% | -21↑15.6% | -25↓18.6% | -21 | |
| Depreciation & Amortization | 0.70↓2.7% | 0.72↓0.3% | 0.72↓1.6% | 0.73↑4.1% | 0.70 | |
| EBITDA | -14↑22.1% | -18↑9.9% | -20↑37.3% | -32↓51.8% | -21 | |
| EBIT | -15↑21.3% | -19↑9.6% | -21↑36.5% | -32↓50.3% | -22 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 0.45↓14.9% | 0.53↑111.7% | -5↓720.3% | -0.55 | |
| Interest Income | 0.00↓100.0% | 0.45↓38.0% | 0.73↑44.4% | 0.50↑2669.8% | 0.02 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 0.20↓96.1% | 5↑782.4% | 0.57 | |
| Non-Operating Income | 0.00↑100.0% | -0.51↓18.5% | -0.43↓105.8% | 8↑1205.6% | 0.58 | |
| Other Income / Expenses | 0.16↓69.6% | 0.51↑117.9% | 0.24↑101.9% | -13↓995.0% | -1 | |
| Income Before Tax | -14↑22.2% | -19↑10.5% | -21↑44.5% | -37↓69.1% | -22 | |
| Income Tax Expense | 0.00 | 0.00↑100.0% | -1↑18.3% | -2↓13.3% | -1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -14↑22.2% | -19↑4.6% | -20↑45.6% | -36↓72.8% | -21 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -14↑22.2% | -19↑4.6% | -20↑45.6% | -36↓72.8% | -21 | |
| Bottom-Line Net Income | -14↑22.2% | -19↑4.6% | -20↑45.6% | -36↓72.8% | -21 | |
| EPS (Basic) | -6.83↑67.6% | -21.10↑25.0% | -28.14↑57.1% | -65.55↑91.2% | -748.77 | |
| EPS (Diluted) | -6.83↑67.6% | -21.10↑25.0% | -28.14↑57.1% | -65.55↑91.2% | -748.77 | |
| Weighted Average Shares | 2↑140.6% | 0.88↑27.2% | 0.69↑26.6% | 0.55↑1874.4% | 0.03 | |
| Weighted Average Diluted Shares | 2↑140.6% | 0.88↑27.2% | 0.69↑26.6% | 0.55↑1874.4% | 0.03 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.